Pathology Labs Replace Microscopes with Digital Imaging
By LabMedica International staff writers Posted on 29 Dec 2011 |
Microscopes are being replaced with digital imaging in pathology laboratories in the southern part of Sweden.
Traditional microscope glass slides are turned into digital images, which are then analyzed by pathologists directly from the computer screen, instead of using regular microscopes.
The revolution, which has already occurred in radiology, is now taking place in pathology. The contracted delivery not only digitizes the slides but also will completely renew IT support for all workflows of the pathology laboratories in the Skåne region.
Labvantage (Somerset, NJ, USA) will deliver a USD 4 million turnkey solution for digitizing the histopathological workflows in the whole region. The system will be possibly the largest such installation in the world and among the first of its kind in northern Europe. The digital slides will reside in Hitachi’s (Tokyo, Japan) Content Platform, which employs distributed object storage. All of the images will be kept well protected and duplicated across several physical discs. This makes the traditional backing up of data unnecessary.
Currently the four pathology laboratories run by Region Skåne produce about 400,000 histological microscope slides a year. The samples are prepared into microscope slides and are then physically distributed to pathologists. Slides are then analyzed using regular microscopes. There is currently limited IT support for the workflow, making it difficult to track the status of pending cases and to identify the bottlenecks in the production workflow.
The difficulties in this method are mostly related to physical slides, which can only reside–and be analyzed–in one place at a time. With the digital pathology in place, all pathologists from all laboratories of Skåne can gain access to all cases and related slides. Together with the introduction of digital pathology, another goal of Region Skåne is to introduce so-called LEAN workflows.
The digitizing will not only ease the distribution of slides for the pathologists’ viewing but will also solve the needs for storage. Swedish law requires Region Skåne to keep all slides for a minimum of 20 years, and today this requires a lot of physical space. It is also difficult to retrieve a particular case from the archive. In the digitized format, the annual production of about 400,000 glass slides will consume 300 terabytes of storage each year.
The unique changeover both in its scope and in scale is to be supplied by Software Point. A key component in the delivery is a new workflow management system, which will manage both the preanalytical and analytical stages of the laboratory process. An adapted version of Software Point’s (Espoo, Finland) C5 LIMS will be in total charge of managing the workflows and tracking all events within. It will maintain a real-time status of each sample, slide, and case, and will ease the work of both laboratory technicians and pathologists with advanced functionalities such as integration to laboratory automation, datamatrix labeling of all objects, and speech recognition for pathologists.
"This is an important milestone for us. Our workflow-centric C5 LIMS, complemented with the best of breed systems from Aperio (Vista, CA, USA) and Hitachi, make up a solution unlike anything else on the market. We see tremendous potential in digital pathology and this is one key element in our strategy for further expanding the position of our LIMS in the healthcare marketplace," comments Andrea Holmberg, CEO of Software Point.
Related Links:
Labvantage
Software Point
Aperio
Traditional microscope glass slides are turned into digital images, which are then analyzed by pathologists directly from the computer screen, instead of using regular microscopes.
The revolution, which has already occurred in radiology, is now taking place in pathology. The contracted delivery not only digitizes the slides but also will completely renew IT support for all workflows of the pathology laboratories in the Skåne region.
Labvantage (Somerset, NJ, USA) will deliver a USD 4 million turnkey solution for digitizing the histopathological workflows in the whole region. The system will be possibly the largest such installation in the world and among the first of its kind in northern Europe. The digital slides will reside in Hitachi’s (Tokyo, Japan) Content Platform, which employs distributed object storage. All of the images will be kept well protected and duplicated across several physical discs. This makes the traditional backing up of data unnecessary.
Currently the four pathology laboratories run by Region Skåne produce about 400,000 histological microscope slides a year. The samples are prepared into microscope slides and are then physically distributed to pathologists. Slides are then analyzed using regular microscopes. There is currently limited IT support for the workflow, making it difficult to track the status of pending cases and to identify the bottlenecks in the production workflow.
The difficulties in this method are mostly related to physical slides, which can only reside–and be analyzed–in one place at a time. With the digital pathology in place, all pathologists from all laboratories of Skåne can gain access to all cases and related slides. Together with the introduction of digital pathology, another goal of Region Skåne is to introduce so-called LEAN workflows.
The digitizing will not only ease the distribution of slides for the pathologists’ viewing but will also solve the needs for storage. Swedish law requires Region Skåne to keep all slides for a minimum of 20 years, and today this requires a lot of physical space. It is also difficult to retrieve a particular case from the archive. In the digitized format, the annual production of about 400,000 glass slides will consume 300 terabytes of storage each year.
The unique changeover both in its scope and in scale is to be supplied by Software Point. A key component in the delivery is a new workflow management system, which will manage both the preanalytical and analytical stages of the laboratory process. An adapted version of Software Point’s (Espoo, Finland) C5 LIMS will be in total charge of managing the workflows and tracking all events within. It will maintain a real-time status of each sample, slide, and case, and will ease the work of both laboratory technicians and pathologists with advanced functionalities such as integration to laboratory automation, datamatrix labeling of all objects, and speech recognition for pathologists.
"This is an important milestone for us. Our workflow-centric C5 LIMS, complemented with the best of breed systems from Aperio (Vista, CA, USA) and Hitachi, make up a solution unlike anything else on the market. We see tremendous potential in digital pathology and this is one key element in our strategy for further expanding the position of our LIMS in the healthcare marketplace," comments Andrea Holmberg, CEO of Software Point.
Related Links:
Labvantage
Software Point
Aperio
Latest Pathology News
- Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy
- Saliva-Based Testing to Enable Early Detection of Cancer, Heart Disease or Parkinson’s
- Advances in Monkeypox Virus Diagnostics to Improve Management of Future Outbreaks
- Nanoneedle-Studded Patch Could Eliminate Painful and Invasive Biopsies
- AI Cancer Classification Tool to Drive Targeted Treatments
- AI-Powered Imaging Enables Faster Lung Disease Treatment
- New Laboratory Method Speeds Diagnosis of Rare Genetic Disease
- New Technology Autonomously Detects AI Hallucinations in Digital Pathology
- Novel Algorithm Rapidly Identifies Cell Types to Improve Cancer Diagnosis
- AI Method Speeds Up Cancer Tracking Using Blood Tests
- New AI Tool Improves Blood Cancer Diagnosis
- Novel Platform Technology Predicts Diseases by Early Detection of Aging Signals in Liver Tissue
- AI Model Detects More Than 170 Cancer Types
- Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer
- Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues
- New At-Home Cervical Cancer Screening Device to Increase Accessibility for Patients
Channels
Clinical Chemistry
view channel
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read more
Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin
Opioid drugs such as fentanyl, morphine, and oxycodone are the primary substances associated with overdose cases in the United States. Standard drug screening procedures typically involve collecting blood,... Read moreMolecular Diagnostics
view channel
mNGS CSF Test Outperforms Traditional Microbiological Testing for Infectious Diseases
Traditional, targeted tests for pathogen identification offer a frustrating guessing game with too many tests and too few answers. Identifying a pathogen is only the first part of the story.... Read more
Point-Of-Care Test to Transform Early-Stage Cervical Cancer Diagnosis
Cervical cancer is the world’s fourth most common cancer in women. When it’s found early, it’s one of the most preventable and treatable cancers. The main screening method is an in-person Pap smear.... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer
Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more
Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance
Structural changes in tumor DNA are among the most damaging genetic alterations in cancer, yet they often go undetected, particularly when tissue samples are degraded or of low quality. These hidden genomic... Read moreMicrobiology
view channel
Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
Critically ill patients in medical intensive care units (MICUs) often suffer from conditions such as acute respiratory distress syndrome (ARDS) or sepsis, which are linked to reduced diversity of gut microbiota... Read more
Portable Molecular POC System Rules Out UTIs in Just 35 Minutes
Urinary tract infections (UTIs) represent a massive burden on patients and healthcare systems. There are over 400 million UTI cases globally each year, of which around 90% are in women. Fast and accurate... Read more
POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques
Diagnosing mucormycosis—an aggressive and often deadly fungal infection—remains a major challenge due to the disease’s rapid progression and the lack of fast, accurate diagnostic tools. The problem became... Read moreTechnology
view channel
New POC Biosensing Technology Improves Detection of Molecular Biomarkers
Traditional diagnostic procedures in medicine typically involve sending a patient’s blood or tissue samples to clinical laboratories, where trained scientists perform testing and data interpretation.... Read more
Enhanced Lab Data Management and AI Critical to Labs of the Future, Finds Survey
Data plays a key role in the transformation of today’s digital laboratories, acting both as a key challenge and a catalyst for innovation, as revealed by a survey of over 150 scientists.... Read moreIndustry
view channel
AMP Releases Best Practice Recommendations to Guide Clinical Laboratories Offering HRD Testing
Homologous recombination deficiency (HRD) testing identifies tumors that are unable to effectively repair DNA damage through the homologous recombination repair pathway. This deficiency is often linked... Read more